Since Novo's blockbuster Ozempic diabetes treatment was approved in the United States in 2017, regulators have greenlighted ...

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

The debate over how to tackle America's obesity epidemic that affects 40% of adults and nearly 20% of children, has sparked ...

Growth stocks are equity shares likely to outperform their peers and the broader market. Here's a list of stocks that contain ...

On Thursday the 42-year-old chart-topping singer pulled off a stunning ruby red Christmas outfit on her daytime talk show .

With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...

Viking Therapeutics shows promise with weight loss drug VK2735 and potential in NASH treatment, making it a potential ...

Gavin and Stacey star James Corden previously opened up about his weight loss and why he stopped using Ozempic ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Eli Lilly & Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...